Cytokines and psychopathology: lessons from interferon-alpha - PubMed

Review

Cytokines and psychopathology: lessons from interferon-alpha

Lucile Capuron et al. Biol Psychiatry. 2004.

Abstract

Interferon-alpha is a potent inducer of the cytokine network and is notorious for causing behavioral alterations. Studies on interferon-alpha-treated patients reveal at least two distinct syndromes: 1) a mood/cognitive syndrome that appears late during interferon-alpha therapy is responsive to antidepressants and is associated with activation of neuroendocrine pathways and altered serotonin metabolism; and 2) a neurovegetative syndrome characterized by psychomotor slowing, and fatigue that appears early during interferon-alpha treatment is antidepressant nonresponsive and may be mediated by alterations in basal ganglia dopamine metabolism. Findings from interferon-alpha may provide important clues regarding the pathophysiology and treatment of cytokine-induced behavioral changes in medically ill patients, while also potentially modeling the development of neuropsychiatric symptoms in patients without medical disorders.

Similar articles

• [Neuro-immune interactions in psychopathology with the example of interferon-alpha-induced depression].

  Capuron L, Dantzer R, Miller AH. Capuron L, et al. J Soc Biol. 2003;197(2):151-6. J Soc Biol. 2003. PMID: 12910630 Review. French.

• Cytokines and brain function: relevance to interferon-alpha-induced mood and cognitive changes.

  Licinio J, Kling MA, Hauser P. Licinio J, et al. Semin Oncol. 1998 Feb;25(1 Suppl 1):30-8. Semin Oncol. 1998. PMID: 9482538 Review.

• Mood and cognitive side effects of interferon-alpha therapy.

  Valentine AD, Meyers CA, Kling MA, Richelson E, Hauser P. Valentine AD, et al. Semin Oncol. 1998 Feb;25(1 Suppl 1):39-47. Semin Oncol. 1998. PMID: 9482539 Review.

• [Neuropsychiatric symptoms related to interferon alpha].

  Małyszczak K, Inglot M, Pawłowski T, Czarnecki M, Rymer W, Kiejna A. Małyszczak K, et al. Psychiatr Pol. 2006 Jul-Aug;40(4):787-97. Psychiatr Pol. 2006. PMID: 17068950 Review. Polish.

• Neuropsychiatric adverse effects of interferon-alpha: recognition and management.

  Raison CL, Demetrashvili M, Capuron L, Miller AH. Raison CL, et al. CNS Drugs. 2005;19(2):105-23. doi: 10.2165/00023210-200519020-00002. CNS Drugs. 2005. PMID: 15697325 Free PMC article. Review.

Cited by

• Affective Immunology: The Crosstalk Between Microglia and Astrocytes Plays Key Role?

  Yang L, Zhou Y, Jia H, Qi Y, Tu S, Shao A. Yang L, et al. Front Immunol. 2020 Aug 20;11:1818. doi: 10.3389/fimmu.2020.01818. eCollection 2020. Front Immunol. 2020. PMID: 32973758 Free PMC article. Review.

• Inflammation and cancer-related fatigue: mechanisms, contributing factors, and treatment implications.

  Bower JE, Lamkin DM. Bower JE, et al. Brain Behav Immun. 2013 Mar;30 Suppl(0):S48-57. doi: 10.1016/j.bbi.2012.06.011. Epub 2012 Jul 6. Brain Behav Immun. 2013. PMID: 22776268 Free PMC article. Review.

• The correlation of inflammation, tryptophan-kynurenine pathway, and suicide risk in adolescent depression.

  Yang S, Han J, Ye Z, Zhou H, Yan Y, Han D, Chen S, Wang L, Feng Q, Zhao X, Kang C. Yang S, et al. Eur Child Adolesc Psychiatry. 2024 Sep 17. doi: 10.1007/s00787-024-02579-4. Online ahead of print. Eur Child Adolesc Psychiatry. 2024. PMID: 39287643

• The association of cognitive and somatic depressive symptoms with depression recognition and outcomes after myocardial infarction.

  Smolderen KG, Spertus JA, Reid KJ, Buchanan DM, Krumholz HM, Denollet J, Vaccarino V, Chan PS. Smolderen KG, et al. Circ Cardiovasc Qual Outcomes. 2009 Jul;2(4):328-37. doi: 10.1161/CIRCOUTCOMES.109.868588. Epub 2009 Apr 25. Circ Cardiovasc Qual Outcomes. 2009. PMID: 20031858 Free PMC article.

• Eating ourselves to death (and despair): the contribution of adiposity and inflammation to depression.

  Shelton RC, Miller AH. Shelton RC, et al. Prog Neurobiol. 2010 Aug;91(4):275-99. doi: 10.1016/j.pneurobio.2010.04.004. Epub 2010 Apr 22. Prog Neurobiol. 2010. PMID: 20417247 Free PMC article. Review.

Publication types

MeSH terms

Substances